University of Chicago
University of Chicago
Chicago, Illinois, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors | Neoplasms by Histologic Type, Neoplasms, Germ Cell, Neoplasms, Germ Cell and Embryonal, neoplasm | Active, not recruiting | Phase 2 | 2026-08-06 | NCT01873326 |